Who owns XILIO THERAPEUTICS INC?
- Ticker: XLO
- CUSIP Number: 98422t100
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors | 2.8M | $3.0M | 0% | Mar 2024 |
|
| FMR | 1.9M | $2.1M | 0% | Mar 2024 |
|
| RiverVest Venture Management | 1.4M | $1.6B | 0% | Mar 2024 |
|
| Rock Springs Capital Management | 1.4M | $1.6M | 0% | Mar 2024 |
|
| Atlas Venture Life Science Advisors | 993k | $1.1M | -64% | Mar 2024 |
|
| Vanguard Group | 903k | $975k | 0% | Mar 2024 |
|
| Balyasny Asset Management | 339k | $366k | 100% | Mar 2024 |
|
| Morgan Stanley | 222k | $240k | 745% | Mar 2024 |
|
| Fil | 219k | $236k | 0% | Mar 2024 |
|
| Geode Capital Management | 85k | $92k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 71k | $77k | -36% | Mar 2024 |
|
| Millennium Management | 70k | $76k | 131% | Mar 2024 |
|
| BlackRock | 45k | $49k | -4% | Mar 2024 |
|
| SevenBridge Financial | 31k | $37k | 100% | Mar 2024 |
|
| PFG Investments | 30k | $32k | 100% | Mar 2024 |
|
| Springbok Capital Management | 30k | $32k | 100% | Mar 2024 |
|
| FNY Investment Advisers | 28k | $29k | 100% | Mar 2024 |
|
| Northern Trust | 18k | $19k | 0% | Mar 2024 |
|
| Summit Trail Advisors | 16k | $17k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 12k | $13k | 0% | Mar 2024 |
|
| Tower Research Capital | 11k | $12k | 187% | Mar 2024 |
|
| Dunhill Financial | 10k | $16k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 2.7k | $3.0k | -4% | Mar 2024 |
|
| Key FInancial | 830.00 | $895.985000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 533.00 | $1.0k | 14% | Mar 2024 |
|
| UBS Group | 201.00 | $216.999600 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 108.00 | $116.996400 | 2% | Mar 2024 |
|
| Qube Research & Technologies | 4.00 | $4.000000 | 0% | Mar 2024 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Octagon Capital Advisors | Dec 2023 | 1.8M | $982k |
| Artal Group | Dec 2023 | 450k | $248k |
| Laurion Capital Management | Dec 2023 | 117k | $64k |
| Arrowpoint Asset Management | Dec 2023 | 83k | $46k |
| Citadel Advisors | Dec 2023 | 51k | $28k |
| Virtu Financial | Dec 2023 | 11k | $6.0k |
| Cullen Frost Bankers | Dec 2023 | 100.00 | $55.000000 |
| Bank of America Corporation | Dec 2023 | 11.00 | $6.000500 |